
Puhua Capital
Description
Puhua Capital, established in 2004 and headquartered in Hangzhou, China, is a prominent equity investment firm specializing in early and growth-stage projects. The firm has built a strong reputation for its strategic investments across a diverse range of high-growth sectors. With a comprehensive investment strategy, Puhua Capital aims to identify and support innovative companies that demonstrate significant potential for market disruption and long-term value creation.
Puhua Capital's investment mandate spans key industries including TMT (Technology, Media, Telecom), healthcare, advanced manufacturing, new consumption, new energy, and environmental protection. This broad yet focused approach allows the firm to capitalize on emerging trends and technological advancements within the Chinese market. The scale of Puhua Capital's operations is substantial, managing over RMB 20 billion (approximately $3 billion USD) across various funds. This considerable capital base enables the firm to deploy significant resources into its portfolio companies, supporting their development from nascent stages through to maturity.
The firm's extensive portfolio boasts over 300 companies, reflecting its active engagement in the venture capital landscape. Puhua Capital is not merely a financial investor; it emphasizes providing strategic guidance and post-investment support to help its portfolio companies navigate market challenges and accelerate growth. This hands-on approach has contributed to a strong track record, with over 50 successful exits, underscoring the firm's ability to identify and nurture ventures that achieve significant returns. Puhua Capital's commitment to fostering innovation and driving industrial transformation positions it as a key player in China's venture capital ecosystem.
Investor Profile
Puhua Capital has backed more than 49 startups, with 22 new investments in the last 12 months alone. The firm has led 12 rounds, about 24% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, United Kingdom, United States.
- Strong thematic focus on Manufacturing, Health Care, Biotechnology.
- Led 11 rounds in the past year.
- Typical check size: $1M – $25M.
Stage Focus
- Series B (29%)
- Series A (24%)
- Seed (18%)
- Series C (14%)
- Series Unknown (10%)
- Series D (2%)
- Series E (2%)
Country Focus
- China (73%)
- United Kingdom (22%)
- United States (2%)
Industry Focus
- Manufacturing
- Health Care
- Biotechnology
- Artificial Intelligence (Ai)
- Medical
- Medical Device
- Automotive
- Industrial
- Autonomous Vehicles
- Robotics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.